The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPP Regulatory News (WPP)

Share Price Information for WPP (WPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 817.20
Bid: 819.60
Ask: 820.00
Change: 4.80 (0.59%)
Spread: 0.40 (0.049%)
Open: 813.60
High: 822.20
Low: 811.40
Prev. Close: 812.40
WPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Executive Performance Share Awards

27 Nov 2020 10:16

RNS Number : 7667G
WPP PLC
27 November 2020
 

FOR IMMEDIATE RELEASE 27 November 2020

 

WPP plc ("WPP")

Executive Performance Share Awards

 

The Executive Performance Share Plan (EPSP) is WPP's long term incentive scheme approved by shareholders at the 2013 Annual General Meeting. On 24 November 2020, awards were made to the 2020 participants which comprise WPP's two Executive Directors, as set out in the table below, and other select senior executives within the Group's operating companies.

Executive Director

Number of shares awarded

Mark Read

460,464

John Rogers

299,554

 

Awards take the form of nil-cost options, which are exercisable over WPP shares or ADRs and the amounts stated represent the maximum possible opportunity.

The extent to which awards become exercisable in 2023 will depend on WPP's performance over the three-year performance period from 1 January 2020 to 31 December 2022.

Awards are subject to three equally weighted performance conditions: three-year average Return on Invested Capital (ROIC), cumulative Adjusted Free Cash Flow (AFCF), and relative Total Shareholder Return (TSR). Achieving the threshold performance requirement will result in a vesting opportunity of 20% for that element. The vesting opportunity will increase on a straight-line basis to 100% of the award for maximum performance.

In approving these awards and performance conditions, the WPP Compensation Committee considered a broad range of factors taking into account feedback collected through consultation with shareholders.

Notes

1) Consultation was undertaken with shareholders in November 2020 following an undertaking given in our 2019 Compensation Committee Report

2) These awards were made in accordance with the terms of the 2020 Directors' Compensation Policy as approved by shareholders on 10 June 2020

3) To the extent that each element of a conditional award does not vest at the end of the three- year performance period it will lapse

4) Additional shares will be awarded at vesting in lieu of dividends on the shares that vest

5) Awards to Executive Directors are subject to an additional two-year post-vesting holding period

Contact:

Chris Wade, WPP

+44 (0)20 7282 4600

 

Richard Oldworth, Buchanan Communications

+44 (0)7710 130634

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mark Read

b)

Position/status

Chief Executive Officer

c)

Initial notification/amendment

Initial notification

2.

Details of the issuer

a)

Full name of the entity

WPP plc

b)

Legal Entity Identifier code

549300LSGBXPYHXGDT93

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of 10 pence each ('Ordinary Shares')

ISIN: JE00B8KF9B49

b)

Nature of the transaction

Grant of conditional awards over WPP plc ordinary shares under the WPP plc Executive Performance Share Plan

c)

Price(s) and volume(s) (Number of WPP ordinary shares or WPP ADRs sold or purchased and price per share/ADR)

Price(s)

Volume(s)

Nil cost option

460,464

 

 

d)

Aggregated information

- Aggregated number

- Aggregated Price

- Total

N/A (single transaction)

 

e)

Date of the transaction

24 November 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

John Rogers

b)

Position/status

Chief Financial Officer

c)

Initial notification/amendment

Initial notification

2.

Details of the issuer

a)

Full name of the entity

WPP plc

b)

Legal Entity Identifier code

549300LSGBXPYHXGDT93

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of 10 pence each ('Ordinary Shares')

ISIN: JE00B8KF9B49

b)

Nature of the transaction

Grant of conditional awards over WPP plc ordinary shares under the WPP plc Executive Performance Share Plan

c)

Price(s) and volume(s) (Number of WPP ordinary shares or WPP ADRs sold or purchased and price per share/ADR)

Price(s)

Volume(s)

Nil cost option

299,554

 

 

d)

Aggregated information

- Aggregated number

- Aggregated Price

- Total

N/A (single transaction)

 

e)

Date of the transaction

24 November 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUBARRRSUAUAA
Date   Source Headline
25th Apr 202412:55 pmRNSNotification of Major Holdings
25th Apr 20247:00 amRNSFirst Quarter Trading Update
2nd Apr 20241:45 pmRNSTotal Voting Rights and Capital
21st Mar 20245:00 pmRNSAnnual Report 2023 on Form 20-F
21st Mar 20244:19 pmRNSAnnual Report 2023 and AGM Notice
21st Mar 20241:19 pmRNSNotification of Trading Update
18th Mar 20244:31 pmRNSVesting of executive share award
13th Mar 20245:10 pmRNSExecutive Performance Share Awards
13th Mar 20245:10 pmRNSVesting of executive share awards
1st Mar 202411:08 amRNSTotal Voting Rights and Capital
27th Feb 20246:08 pmRNSNotification of Major Holdings
22nd Feb 20247:00 amRNS2023 Preliminary Results
8th Feb 20248:00 amRNSInvestment
7th Feb 202410:29 amRNSNotification of Major Holdings
1st Feb 202412:42 pmRNSTotal Voting Rights and Capital
30th Jan 20247:00 amRNSCapital Markets Day 2024
12th Jan 202412:45 pmRNSNotification of CMD and 2023 Preliminary Results
2nd Jan 20243:03 pmRNSTotal Voting Rights and Capital
11th Dec 20234:38 pmRNSDirector / PDMR Transaction notification
11th Dec 20233:02 pmRNSNotification of Major Holdings
8th Dec 202311:47 amRNSExecutive Share Awards
1st Dec 20235:04 pmRNSTotal Voting Rights and Capital
21st Nov 20231:05 pmRNSAcquisition
16th Nov 20233:23 pmRNSDIRECTOR / PDMR TRANSACTION NOTIFICATION
1st Nov 20232:17 pmRNSTotal Voting Rights and Capital
26th Oct 20237:00 amRNSThird Quarter Trading Update
10th Oct 20234:59 pmRNSNotification of Trading Update
2nd Oct 202311:58 amRNSTotal Voting Rights and Capital
7th Sep 20232:49 pmRNSBoard Change
1st Sep 20239:57 amRNSTotal Voting Rights and Capital
7th Aug 20233:01 pmRNSDirector / PDMR Transaction notification
4th Aug 20237:00 amRNS2023 Interim Results
1st Aug 20234:18 pmRNSTotal Voting Rights and Capital
11th Jul 202312:36 pmRNSNotification of Interim Results
3rd Jul 202311:50 amRNSTotal Voting Rights and Capital
20th Jun 20231:00 pmRNSAcquisition
1st Jun 202310:48 amRNSTotal Voting Rights and Capital
17th May 20232:46 pmRNSResults of AGM
16th May 202312:00 pmRNSVesting of executive share award
9th May 20234:15 pmRNSExecutive Share Awards
2nd May 202311:11 amRNSTotal Voting Rights and Capital
27th Apr 20237:00 amRNSFirst Quarter Trading Update
20th Apr 202311:00 amRNSAcquisition
11th Apr 202310:30 amRNSUpdate re FGS Global
3rd Apr 202312:50 pmRNSTotal Voting Rights and Capital
28th Mar 202310:40 amRNSNotification of Trading Update
27th Mar 20233:00 pmRNSAcquisition
27th Mar 20232:41 pmRNSExecutive Performance Share Awards
24th Mar 20237:00 amRNSAnnual Report 2022 on Form 20-F
23rd Mar 20234:21 pmRNSAnnual Report 2022 and AGM Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.